J C Bosomworth - Concepedia

Author

J C Bosomworth

Also Known As

J Bosomworth, J C Bosomworth, J. C. Bosomworth, JANET C. BOSOMWORTH, Janet C Bosomworth, Janet C. Bosomworth

Publications

906

Citations

H-Index

Concepts

All Affiliations

J C Bosomworth is an author at Eli Lilly (United States) specializing in psychiatry, social sciences, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	253
2	Social Sciences	4	4	253
3	Pharmacology	4	4	253
4	Psychiatry	4	4	253
5	Neuroscience	1	1	118

J C Bosomworth

Publications

532

Citations

H-Index

Page 1

	Year	Citations
A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major Depression Gary D. Tollefson, J C Bosomworth, John H. Heiligenstein, International Psychogeriatrics	1995	141
The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam Louis Lemberger, Howard Rowe, J C Bosomworth, Clinical Pharmacology & Therapeutics Psychotropic MedicationPsychopharmacologyPharmacotherapyMg DiazepamDiazepam Disposition	1988	118
Low-dose fluoxetine therapy for depression. J. F. Wernicke, S R Dunlop, Bruce E. Dornseif, PubMed PsychiatryMedicinePsychotropic MedicationLow-dose Fluoxetine TherapyDepression	1988	101
Use of a serotonin re-uptake inhibitor, fluoxetine, in the treatment of obesity. Louise R. Levine, S. Rosenblatt, J C Bosomworth PubMed	1987	92
High-Dose Fluoxetine Charles M. Beasley, Mary E. Sayler, J C Bosomworth, Journal of Clinical Psychopharmacology	1991	46
Efficacy and safety of morning versus evening fluoxetine administration. Roland W. Usher, Charles M. Beasley, J C Bosomworth PubMed Fluoxetine AdministrationPsychotropic MedicationPsychopharmacologyPharmacotherapyMental Health	1991	18
Fluoxetine at 20 mg per day: the recommended and therapeutic dose in the treatment of depression. J. F. Wernicke, J C Bosomworth, EARLEEN ASHBROOK PubMed Therapeutic DosePsychiatryMedicinePsychotropic MedicationPsychopharmacology	1989	16

Page 1